AcariaHealth Highlights National Biosimilars Education Efforts with Three Events

Sessions with AcariaHealth, the National Association of Specialty Pharmacy (NASP), and Reuters Events deliver actionable insights on biosimilar adoption, patient access, and specialty pharmacy readiness  

ORLANDO, Fla., Nov. 20, 2025 /PRNewswire/ -- AcariaHealth, a leading specialty pharmacy and a company of Centene Corporation (NYSE: CNC), announced the completion of three national educational events in October focused on the evolving U.S. biosimilars landscape. Hosted in collaboration with NASP, Reuters Events, and through an AcariaHealth-led webinar, the sessions provided healthcare professionals with actionable, real-world guidance to support biosimilar utilization, reduce access barriers, and improve patient outcomes. On-demand recordings of all three programs are now available. 

"AcariaHealth is committed to equipping healthcare professionals with the knowledge and tools needed to confidently integrate biosimilars into patient care," said Jessica Ciccolella-Kahl, CEO of AcariaHealth. "Education is essential to improving access and ensuring patients benefit from safe, effective, and affordable therapies." 

NASP Lunch & Learn: "Biosimilars Unveiled: Strategies for Success in Specialty Pharmacy" 
Speaker: Kathleen Stenberg, PharmD, CSP, Lead Specialty Pharmacist, AcariaHealth 

This session delivered foundational biosimilar education, addressed common questions from providers and patients, and outlined strategies for overcoming substitution and workflow challenges within specialty pharmacy. 

Watch the recording: NASP Lunch & Learn Replay

Reuters Events Panel: "Biosimilars in U.S. Healthcare: Adoption, Opportunities, and Outcomes" 
Panelist: Kathleen Stenberg, PharmD, CSP, Lead Specialty Pharmacist, AcariaHealth 

Industry leaders shared perspectives on biosimilar adoption trends, policy considerations, and access challenges. Dr. Stenberg offered specialty-pharmacy insights focused on patient care, payer expectations, and operational readiness for biosimilars. 

Watch the recording: Reuters Events Replay 

AcariaHealth Webinar: "Biosimilars in Practice: Maintaining Access and Prioritizing Patient Care" 
Speakers: 

• Alysha Robinson, PharmD, CSP — Director, Specialty Pharmacy Program Management
• Kathleen Stenberg, PharmD, CSP — Lead Specialty Pharmacist
• Robin Waida — Director, Physician Sales

The AcariaHealth-hosted webinar covered biosimilar fundamentals, addressed common misconceptions, and explored both patient and provider hesitancy. Presenters also shared actionable strategies for supporting successful biosimilar integration across care settings. 

Watch the recording: AcariaHealth Webinar Replay 

Key Insights Across All Sessions 

• Current regulatory and market updates shaping biosimilar adoption 

• Communication approaches to reduce provider and patient hesitancy 

• System-level considerations, including substitution rules, payer dynamics, and workflow optimization  

About AcariaHealth 

AcariaHealth is a national specialty pharmacy dedicated to supporting patients with complex conditions through personalized care and clinical expertise. As a Centene company, AcariaHealth leverages the strength of the largest Medicaid managed care organization to deliver transformative outcomes across the country. 

Learn more: AcariaHealth.com 
Follow us on LinkedIn 

SOURCE AcariaHealth